UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to aggressive tumor phenotype and identification of patients at high risk for relapse

European journal of surgical oncology, 2014-03, Vol.40 (3), p.289-296

2014

Volltextzugriff (PDF)

Development of a Comprehensive Model for Diffusion-Controlled Free-Radical Copolymerization Reactions

Macromolecules, 2002-05, Vol.35 (10), p.4155-4166

2002

Volltextzugriff (PDF)

High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma

Neoplasma, 2017, Vol.64 (4), p.633-639

2017

Volltextzugriff (PDF)

The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma

Histopathology, 2007-02, Vol.50 (3), p.338-347

2007

Volltextzugriff (PDF)

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma

European journal of surgical oncology, 2007-04, Vol.33 (3), p.294-300

2007

Volltextzugriff (PDF)

Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome

Modern pathology, 2006-04, Vol.19 (4), p.556-563

2006

Volltextzugriff (PDF)

The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas

Cancer letters, 2007-02, Vol.246 (1), p.262-267

2007

Volltextzugriff (PDF)

Semantic Web user interfaces – A model and a review

Data & knowledge engineering, 2018-05, Vol.115, p.214-227

2018

Volltextzugriff (PDF)

The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer

Journal of clinical pathology, 2004-05, Vol.57 (5), p.523-528

2004

Volltextzugriff (PDF)

PPARγ expression in breast cancer: clinical value and correlation with ERβ

Histopathology, 2005-01, Vol.46 (1), p.37-42

2005

Volltextzugriff (PDF)

Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression

Histology and histopathology, 2007-08, Vol.22 (8), p.825

2007

Volltextzugriff (PDF)

The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2005-04, Vol.113 (4), p.246-255

2005

Volltextzugriff (PDF)

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

Climacteric : the journal of the International Menopause Society, 2005-12, Vol.8 (4), p.342-351

2005

Volltextzugriff (PDF)

Abnormal α-catenin expression in invasive breast cancer correlates with poor patient survival

Histopathology, 2002-06, Vol.40 (6), p.536-546

2002

Volltextzugriff (PDF)

Expression patterns of β-catenin in in situ and invasive breast cancer

European journal of surgical oncology, 2001-02, Vol.27 (1), p.31-36

2001

Volltextzugriff (PDF)

Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2005-10, Vol.113 (10), p.693-701

2005

Volltextzugriff (PDF)

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells

APMIS : acta pathologica, microbiologica et immunologica Scandinavica, 2003-11, Vol.111 (11), p.1027-1036

2003

Volltextzugriff (PDF)

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

Pathobiology (Basel), 2005-01, Vol.72 (5), p.241-249

2005

Volltextzugriff (PDF)

Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

The Journal of surgical research, 2001-08, Vol.99 (2), p.161-168

2001

Volltextzugriff (PDF)

Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach

Oncology, 1993-11, Vol.50 (6), p.445-449

1993

Volltextzugriff (PDF)

Phytoestrogen supplementation: a case report of male breast cancer

European journal of cancer prevention, 2004-12, Vol.13 (6), p.481-484

2004

Volltextzugriff (PDF)

Survival in primary inoperable breast cancer patients

European journal of gynaecological oncology, 2004, Vol.25 (3), p.367

2004

Volltextzugriff (PDF)

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining

Histopathology, 1999-04, Vol.34 (4), p.310-319

1999

Volltextzugriff (PDF)

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

Annals of oncology, 1998-09, Vol.9 (9), p.1031-1034

1998

Volltextzugriff (PDF)

Mathematical modeling of diffusion-controlled free-radical terpolymerization reactions

Journal of applied polymer science, 2003-04, Vol.88 (1), p.161-176

2003

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(92)
Mit Volltextzugriff
(86)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Y-box-binding protein 1 (YB1) in breast carcinomas: Relation to aggressive tumor phenotype and identification of patients at high risk for relapse

Development of a Comprehensive Model for Diffusion-Controlled Free-Radical Copolymerization Reactions

High Farnesoid X Receptor (FXR) expression is a strong and independent prognosticator in invasive breast carcinoma

The clinicopathological and prognostic significance of membrane type 1 matrix metalloproteinase (MT1-MMP) and MMP-9 according to their localization in invasive breast carcinoma

Clinicopathological and prognostic significance of vascular endothelial growth factors (VEGF)-C and -D and VEGF receptor 3 in invasive breast carcinoma

Study of phospho-β-catenin subcellular distribution in invasive breast carcinomas in relation to their phenotype and the clinical outcome

The prognostic value of the topographic distribution of uPAR expression in invasive breast carcinomas

Semantic Web user interfaces – A model and a review

The favourable prognostic value of oestrogen receptor β immunohistochemical expression in breast cancer

PPARγ expression in breast cancer: clinical value and correlation with ERβ

Lymphatic and blood vessel morphometry in invasive breast carcinomas: relation with proliferation and VEGF-C and -D proteins expression

The multifunctional role of the immunohistochemical expression of MMP-7 in invasive breast cancer

Clinical effects of tibolone in postmenopausal women after 5 years of tamoxifen therapy for breast cancer

Abnormal α-catenin expression in invasive breast cancer correlates with poor patient survival

Expression patterns of β-catenin in in situ and invasive breast cancer

Effect of different ERK2 protein localizations on prognosis of patients with invasive breast carcinoma

The favorable prognostic impact of tissue inhibitor of matrix metalloproteinases-1 protein overexpression in breast cancer cells

Overexpression of cyclooxygenase-2 is associated with a favorable prognostic phenotype in breast carcinoma

Can Expression of Apoptosis Genes, bcl-2 and bax, Predict Survival and Responsiveness to Chemotherapy in Node-Negative Breast Cancer Patients?

Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach

Phytoestrogen supplementation: a case report of male breast cancer

Survival in primary inoperable breast cancer patients

bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining

First-line chemotherapy with paclitaxel by three-hour infusion and carboplatin in advanced breast cancer (final report): A phase II study conducted by the Hellenic Cooperative Oncology Group

Mathematical modeling of diffusion-controlled free-radical terpolymerization reactions

Suchergebnisse filtern